IL135435A0 - Dofetilide polymorphs - Google Patents

Dofetilide polymorphs

Info

Publication number
IL135435A0
IL135435A0 IL13543598A IL13543598A IL135435A0 IL 135435 A0 IL135435 A0 IL 135435A0 IL 13543598 A IL13543598 A IL 13543598A IL 13543598 A IL13543598 A IL 13543598A IL 135435 A0 IL135435 A0 IL 135435A0
Authority
IL
Israel
Prior art keywords
dofetilide polymorphs
dofetilide
polymorphs
Prior art date
Application number
IL13543598A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL135435(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of IL135435A0 publication Critical patent/IL135435A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL13543598A 1997-10-27 1998-10-09 Dofetilide polymorphs IL135435A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs
PCT/EP1998/006641 WO1999021829A1 (en) 1997-10-27 1998-10-09 Dofetilide polymorphs

Publications (1)

Publication Number Publication Date
IL135435A0 true IL135435A0 (en) 2001-05-20

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13543598A IL135435A0 (en) 1997-10-27 1998-10-09 Dofetilide polymorphs

Country Status (47)

Country Link
US (1) US6124363A (zh)
EP (1) EP1027329B1 (zh)
JP (1) JP3569495B2 (zh)
KR (1) KR100366167B1 (zh)
CN (1) CN1146537C (zh)
AP (1) AP906A (zh)
AR (1) AR015193A1 (zh)
AT (1) ATE232199T1 (zh)
AU (1) AU737668B2 (zh)
BG (1) BG64125B1 (zh)
BR (1) BR9813308A (zh)
CA (1) CA2307121C (zh)
CO (1) CO4970768A1 (zh)
DE (1) DE69811256T2 (zh)
DK (1) DK1027329T3 (zh)
DZ (1) DZ2632A1 (zh)
EA (1) EA002656B1 (zh)
ES (1) ES2190620T3 (zh)
GB (1) GB9722662D0 (zh)
GT (1) GT199800165A (zh)
HK (1) HK1033933A1 (zh)
HN (1) HN1998000165A (zh)
HR (1) HRP20000247B1 (zh)
HU (1) HUP0004735A3 (zh)
ID (1) ID24658A (zh)
IL (1) IL135435A0 (zh)
IS (1) IS2179B (zh)
MA (1) MA24683A1 (zh)
MY (1) MY123352A (zh)
NO (1) NO325630B1 (zh)
NZ (1) NZ503785A (zh)
OA (1) OA11350A (zh)
PA (1) PA8462001A1 (zh)
PE (1) PE122199A1 (zh)
PL (1) PL197379B1 (zh)
PT (1) PT1027329E (zh)
SA (1) SA98190834B1 (zh)
SI (1) SI1027329T1 (zh)
SK (1) SK5862000A3 (zh)
TN (1) TNSN98193A1 (zh)
TR (1) TR200001135T2 (zh)
TW (1) TW449589B (zh)
UA (1) UA67755C2 (zh)
UY (2) UY25222A1 (zh)
WO (1) WO1999021829A1 (zh)
YU (1) YU24000A (zh)
ZA (1) ZA989719B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ2017772A3 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
ZA989719B (en) 2000-04-26
PL197379B1 (pl) 2008-03-31
SI1027329T1 (en) 2003-04-30
JP3569495B2 (ja) 2004-09-22
NO20002191D0 (no) 2000-04-27
HUP0004735A2 (hu) 2001-10-28
TW449589B (en) 2001-08-11
DZ2632A1 (fr) 2003-03-08
BG64125B1 (bg) 2004-01-30
PT1027329E (pt) 2003-04-30
HRP20000247B1 (en) 2002-08-31
MA24683A1 (fr) 1999-07-01
PE122199A1 (es) 1999-12-02
CO4970768A1 (es) 2000-11-07
EA200000365A1 (ru) 2000-12-25
NO325630B1 (no) 2008-06-30
PL340805A1 (en) 2001-02-26
HRP20000247A2 (en) 2000-10-31
IS2179B (is) 2006-12-15
TR200001135T2 (tr) 2000-09-21
JP2001521023A (ja) 2001-11-06
UY25222A1 (es) 2000-12-29
KR20010031439A (ko) 2001-04-16
WO1999021829A1 (en) 1999-05-06
HK1033933A1 (en) 2001-10-05
NO20002191L (no) 2000-04-27
CA2307121A1 (en) 1999-05-06
AU2151299A (en) 1999-05-17
HN1998000165A (es) 1999-02-09
YU24000A (sh) 2003-02-28
DK1027329T3 (da) 2003-02-24
TNSN98193A1 (fr) 2005-03-15
UY25341A1 (es) 1999-09-27
BR9813308A (pt) 2000-08-22
CN1278246A (zh) 2000-12-27
CN1146537C (zh) 2004-04-21
GT199800165A (es) 2000-04-19
DE69811256T2 (de) 2003-09-18
KR100366167B1 (ko) 2003-01-09
IS5426A (is) 2000-03-31
EA002656B1 (ru) 2002-08-29
MY123352A (en) 2006-05-31
US6124363A (en) 2000-09-26
EP1027329A1 (en) 2000-08-16
AP9801371A0 (en) 1998-12-31
GB9722662D0 (en) 1997-12-24
AP906A (en) 2000-11-30
ES2190620T3 (es) 2003-08-01
SK5862000A3 (en) 2001-10-08
ID24658A (id) 2000-07-27
BG104373A (en) 2000-12-29
EP1027329B1 (en) 2003-02-05
AU737668B2 (en) 2001-08-30
CA2307121C (en) 2006-12-05
SA98190834B1 (ar) 2006-08-21
HUP0004735A3 (en) 2001-12-28
ATE232199T1 (de) 2003-02-15
UA67755C2 (uk) 2004-07-15
AR015193A1 (es) 2001-04-18
NZ503785A (en) 2004-11-26
DE69811256D1 (de) 2003-03-13
PA8462001A1 (es) 2000-05-24
OA11350A (en) 2003-12-17

Similar Documents

Publication Publication Date Title
EP1007563A4 (en) HM74A RECEPTOR
HK1017348A1 (en) Triazinylaminostilbene compounds
HK1029035A1 (en) Teeth-cleansing means
GB9708805D0 (en) Compounds
GB9725415D0 (en) Advance arrangement
IL134661A0 (en) Nootropics
EP0999205A4 (en) AMINOCYCLOALKAN CONNECTIONS
HRP20000247B1 (en) Dofetilide polymorphs
IL133729A0 (en) Compounds
PL340723A1 (en) Structural member
GB9701050D0 (en) Structural member
GB9708589D0 (en) Seurity means
GB9825225D0 (en) Compounds
GB2325022B (en) Stay
GB2314014B (en) Closure-arrangements for loose-covers
GB2329420B (en) Stay
GB9703121D0 (en) Advance arrangement
GB9705391D0 (en) Pyridine compounds
CA81596S (en) Structural member
HU9700096V0 (en) Aid for run
GB9716515D0 (en) Chiropodist aid
ZA9810108B (en) Moving arrangement
GB9704905D0 (en) Neurosteroids
TW345061U (en) Combined-disk for screw-pads
GB9714421D0 (en) Structural elements

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees